Enteric disease testing market to grow to $5.86B by 2035, driven by foodborne disease surveillance and molecular diagnostics.

The global enteric disease testing market is projected to grow from $4.08 billion in 2025 to $5.86 billion by 2035, at a CAGR of 3.7%. Growth is fueled by rising foodborne and waterborne diseases, demand for rapid pathogen detection, and adoption of multiplex molecular diagnostics and lab automation. North America leads the market, with the U.S. expected to reach $1.53 billion by 2035, while Asia-Pacific is the fastest-growing region due to urbanization and increased healthcare investment. Advances in molecular testing and public health surveillance are key drivers of this expansion.